Back to Australia
Australia
10 October 2026
Women with PMOS should get subsidised weight-loss drugs, Australian advocates say
With GLP-1s to treat the condition not specifically approved by the TGA, patients are being prescribed them off-label The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is urging for GLP-1 drugs to be approved on the Pharmaceutical Benefits Scheme for people living with the condition.
About this report
Downunder Voices provides an independently written summary and community perspective based on information published by the original source. The original publisher remains responsible for its reporting.
Join our community
Follow Downunder Voices
Join thousands of readers following news and community stories from Australia, New Zealand and the Pacific.
